AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Viral Hepatitis

Scientists Discover Hepatitis C Virus Can Remain Infectious Outside of the Body for Up to 6 Weeks

Ronald Valdiserri

A recent study by researchers from the Yale Schools of Medicine and Public Health revealed that the hepatitis C virus (HCV) can remain infectious for up to 6 weeks on surfaces at room temperature—resulting in a much longer period for potential transmission than was previously appreciated.  Prior to this study, scientists believed that HCV could…

Online Expert Advice for Clinicians Treating Hepatitis C Now Available

Ronald Valdiserri

Up-to-date guidance for the treatment of hepatitis C virus (HCV) infection is now available for healthcare providers from HCVguidelines.org, a new online resource launched this week by the American Association for the Study of Liver Diseases  (AASLD) and the Infectious Diseases Society of America  (IDSA), in collaboration with the International Antiviral Society-USA   (IAS-USA).  These guidelines are…

FDA approves Sovaldi for chronic hepatitis C

FDA

Drug is third with breakthrough therapy designation to receive FDA approval The U.S. Food and Drug Administration today approved Sovaldi (sofosbuvir) to treat chronic hepatitis C virus (HCV) infection. Sovaldi is the first drug that has demonstrated safety and efficacy to treat certain types of HCV infection without the need for co-administration of interferon. “Today’s…

Viral Hepatitis Training Resources for Health Care Providers/Professionals

Jonathan Mermin

Health care providers at all levels of the health care system can help reduce health disparities and prevent viral hepatitis by learning more about the prevention, care, and treatment of this disease. This is one of the goals of the Action Plan for the Prevention, Care and Treatment of Viral Hepatitis [PDF 673KB], to “Build a…

Viral Hepatitis Policy Meets Practice at the Liver Meeting

Photo of author speaking at meeting

Earlier this month, the “Liver Meeting” – the annual meeting of the American Association for the Study of Liver Diseases (AASLD )– took place in Washington, DC. As part of a session re-capping the major viral hepatitis highlights from the conference, I had the pleasure of sharing with several thousand scientists and healthcare professionals from around…

Viral Hepatitis Action Plan 2012 Progress Report Released

viral_hepatitis_support

In a new report, partners from across the U.S. government have shared an update on progress made during 2012 in implementing the Action Plan for the Prevention, Care and Treatment of Viral Hepatitis. This is our second such progress report; a report on the first year of implementing the Action Plan was published last October….

Viral Hepatitis Prevention Coordinators Convene in DC

Drs. Ron Valdiserri, Ellie McCance-Katz, and John Ward dicussing federal viral hepatitis initiatives with Viral Hepatitis Prevention Coordinators from across the country.

Last week I had the opportunity to discuss the federal response to viral hepatitis with some of our key allies in the states: the CDC-funded Adult Viral Hepatitis Prevention Coordinators who had assembled in Washington, DC for the third National Hepatitis Technical Assistance meeting organized and hosted by the National Alliance of State and Territorial…

Together on the Pathways to Wellness: Recovery and Efforts to Strengthen Viral Hepatitis Services

Ronald Valdiserri

Throughout September’s observance of National Recovery Month, individuals, organizations, and communities across the nation celebrated recovery from mental health issues and addiction challenges. Given the significant role that drug-using behaviors can play in the transmission of viral hepatitis, and the fact that alcohol intake often worsens liver disease among persons with chronic viral hepatitis, National Recovery…

Page 2 of 121234...10...Last »